Regulatory Affairs - FarmavitaR - Regulatory affairs network

Regulatory Affairs

Business Strategies

Sunday, 11 March 2007 23:11 Regulatory Affairs - Other issues

Pharmaceutical Business Development Strategies

At the seminar entitled RUSSIAN GENERIC PHARMACEUTICAL MARKET which was hold on January 18th, 2007 in Istanbul, TURKEY the CEO of Farmavita.Net has presented lecture about strategies for pharmaceutical business development. Available strategists are presented as cost driven, innovation driven, market driven and those utilizing the power of alliances and networking.

Hospital in the Home

Thursday, 08 March 2007 08:50 shweta Regulatory Affairs - Regulatory Affairs News

HITH: Concept and clinical guidelines

Hospital in the Home (HITH) is the provision of hospital care in the comfort of the persons own home. In this patients are regarded as hospital inpatients and remain under the care of their treating doctor in the hospital, they receive the same treatment that they have been received in a hospital bed. Patients may be able to receive all their hospital care in HITH. Participation in HITH is voluntary - patients and their carers must agree to have their care provided at home. There are no additional charges to patients for being in HITH and it is available to public patients from the 43 participating public hospitals across the state.

eCTD viewer/validator

Saturday, 27 January 2007 00:50 Zdravko Mauko Regulatory Affairs - General Gulielines

eCTD Viewer and Validator

GECCO is a new eCTD Viewer that provides a uniform and consistent view of eCTDs in the different regions.

Paediatric Medicines

Friday, 26 January 2007 16:04 Zdravko Mauko Regulatory Affairs - General Gulielines

New Legislation for Pediatric Medicines

On 23 October 2006, the Council of the European Union approved all the compromise amendments to the proposal for a Regulation on Medicinal Products for Paediatric Use which were agreed at its second Parliamentary reading. The Regulation was officially published on 27 December 2006 and will enter into force on 26 January 2007.

Open Source Pharmaceuticals - New Business Model

Friday, 12 January 2007 23:43 Regulatory Affairs - Other issues

Open Source Pharmaceuticals - New Business Model

"Open source" as applied to culture defines a culture in which intellectual property is made generally available. Participants in such a culture are able to improve and modify those products and redistribute them back into the community. Farmavita.Net is now inviting proposals for "open source pharmaceutical projects". Web 2.0 based software available at www.farmavita.net is allowing knowledge sharing and management of complex international, multi-center projects.